DNA-BINDING CHARACTERISTICS OF ACRIDINYLMETHANESULFONANILIDE DRUGS - COMPARISON WITH ANTITUMOUR PROPERTIES

被引：167
|
作者：
WARING, MJ
机构：
[1] UNIV AUCKLAND,DEPT CELL BIOL,AUCKLAND,NEW ZEALAND
[2] CANC CHEMOTHERAPY LAB,AUCKLAND,NEW ZEALAND
来源：
EUROPEAN JOURNAL OF CANCER | 1976年 / 12卷 / 12期
关键词：
D O I：
10.1016/0014-2964(76)90066-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：995 / 1001
页数：7
相关论文
共 50 条
  • [1] DNA-BINDING AND DNA-CLEAVING PROPERTIES OF A SYNTHETIC MODEL AGAGLU RELATED TO THE ANTITUMOUR DRUGS AMSA AND BLEOMYCIN
    BAILLY, C
    KENANI, A
    HELBECQUE, N
    BERNIER, JL
    HOUSSIN, R
    HENICHART, JP
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1988, 152 (02) : 695 - 702
  • [2] EFFECTS OF DNA-BINDING DRUGS ON TRANSCRIPTION
    CROTHERS, DM
    PHILLIPS, DR
    STRANEY, D
    STUDIA BIOPHYSICA, 1984, 104 (1-3): : 121 - 121
  • [3] REPRESSORS, PROMOTORS AND DNA-BINDING DRUGS
    BAGULEY, BC
    NEW ZEALAND MEDICAL JOURNAL, 1977, 86 (595) : 246 - 247
  • [4] DNA POLYINTERCALATION - COMPARISON OF DNA-BINDING PROPERTIES OF AN ACRIDINE DIMER AND TRIMER
    GAUGAIN, B
    MARKOVITS, J
    LEPECQ, JB
    ROQUES, BP
    FEBS LETTERS, 1984, 169 (02): : 123 - 126
  • [5] ANTITUMOUR DRUGS AND DNA
    BAGULEY, BC
    NEW ZEALAND MEDICAL JOURNAL, 1977, 86 (594) : 203 - 203
  • [6] INFLUENCE OF DNA-BINDING DRUGS ON CHROMATIN CONDENSATION
    SEN, D
    CROTHERS, DM
    BIOCHEMISTRY, 1986, 25 (07) : 1503 - 1509
  • [7] Challenging transcription by DNA-binding antitumor drugs
    Portugal, Jose
    BIOCHEMICAL PHARMACOLOGY, 2018, 155 : 336 - 345
  • [8] Induction of fetal hemoglobin by DNA-binding drugs
    Gambari, R
    Fibach, E
    MINERVA BIOTECNOLOGICA, 2003, 15 (02) : 145 - 151
  • [9] INTERCALATING DRUGS - DNA-BINDING AND MOLECULAR PHARMACOLOGY
    WILSON, WD
    JONES, RL
    ADVANCES IN PHARMACOLOGY AND CHEMOTHERAPY, 1981, 18 : 177 - 222
  • [10] DNA-binding of drugs used in medicinal therapies
    Bischoff, G
    Hoffmann, S
    CURRENT MEDICINAL CHEMISTRY, 2002, 9 (03) : 321 - 348
12345